BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 30626117)

  • 1. Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota.
    Wisniewski PJ; Dowden RA; Campbell SC
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30626117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Western diets, gut dysbiosis, and metabolic diseases: Are they linked?
    Martinez KB; Leone V; Chang EB
    Gut Microbes; 2017 Mar; 8(2):130-142. PubMed ID: 28059614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.
    Cani PD; Plovier H; Van Hul M; Geurts L; Delzenne NM; Druart C; Everard A
    Nat Rev Endocrinol; 2016 Mar; 12(3):133-43. PubMed ID: 26678807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.
    Kang C; Wang B; Kaliannan K; Wang X; Lang H; Hui S; Huang L; Zhang Y; Zhou M; Chen M; Mi M
    mBio; 2017 May; 8(3):. PubMed ID: 28536285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction.
    Mavilio M; Marchetti V; Fabrizi M; Stöhr R; Marino A; Casagrande V; Fiorentino L; Cardellini M; Kappel B; Monteleone I; Garret C; Mauriello A; Monteleone G; Farcomeni A; Burcelin R; Menghini R; Federici M
    Cell Rep; 2016 Jul; 16(3):731-43. PubMed ID: 27373162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota in health and disease: an overview focused on metabolic inflammation.
    Nagpal R; Kumar M; Yadav AK; Hemalatha R; Yadav H; Marotta F; Yamashiro Y
    Benef Microbes; 2016; 7(2):181-94. PubMed ID: 26645350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-3 polyunsaturated fatty acids: An innovative strategy against obesity and related metabolic disorders, intestinal alteration and gut microbiota dysbiosis.
    Bellenger J; Bellenger S; Escoula Q; Bidu C; Narce M
    Biochimie; 2019 Apr; 159():66-71. PubMed ID: 30690133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal Androgen Exposure Causes Persistent Gut Microbiota Dysbiosis Related to Metabolic Disease in Adult Female Rats.
    Moreno-Indias I; Sánchez-Alcoholado L; Sánchez-Garrido MÁ; Martín-Núñez GM; Pérez-Jiménez F; Tena-Sempere M; Tinahones FJ; Queipo-Ortuño MI
    Endocrinology; 2016 Dec; 157(12):4888-4898. PubMed ID: 27700135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?
    Brahe LK; Astrup A; Larsen LH
    Adv Nutr; 2016 Jan; 7(1):90-101. PubMed ID: 26773017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiome and Obesity: A Plausible Explanation for Obesity.
    Sanmiguel C; Gupta A; Mayer EA
    Curr Obes Rep; 2015 Jun; 4(2):250-61. PubMed ID: 26029487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota: From Microorganisms to Metabolic Organ Influencing Obesity.
    Stephens RW; Arhire L; Covasa M
    Obesity (Silver Spring); 2018 May; 26(5):801-809. PubMed ID: 29687647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifidobacteria attenuate the development of metabolic disorders, with inter- and intra-species differences.
    Zhu G; Ma F; Wang G; Wang Y; Zhao J; Zhang H; Chen W
    Food Funct; 2018 Jun; 9(6):3509-3522. PubMed ID: 29892745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the gut microbiota on inflammation, obesity, and metabolic disease.
    Boulangé CL; Neves AL; Chilloux J; Nicholson JK; Dumas ME
    Genome Med; 2016 Apr; 8(1):42. PubMed ID: 27098727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal microbiota and the immune system in metabolic diseases.
    Sittipo P; Lobionda S; Lee YK; Maynard CL
    J Microbiol; 2018 Mar; 56(3):154-162. PubMed ID: 29492872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota, diet, and obesity-related disorders-The good, the bad, and the future challenges.
    Portune KJ; Benítez-Páez A; Del Pulgar EM; Cerrudo V; Sanz Y
    Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27287778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the gut microbiota in energy metabolism and metabolic disease.
    Cani PD; Delzenne NM
    Curr Pharm Des; 2009; 15(13):1546-58. PubMed ID: 19442172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Emulsifier-Glycerol Monolaurate Induces Metabolic Syndrome, Gut Microbiota Dysbiosis, and Systemic Low-Grade Inflammation in Low-Fat Diet Fed Mice.
    Jiang Z; Zhao M; Zhang H; Li Y; Liu M; Feng F
    Mol Nutr Food Res; 2018 Feb; 62(3):. PubMed ID: 29131494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.